First Time Loading...

Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832

Watchlist Manager
Shenzhen New Industries Biomedical Engineering Co Ltd Logo
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Watchlist
Price: 70.7 CNY -2.19% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one Shenzhen New Industries Biomedical Engineering Co Ltd stock under the Base Case scenario is 68.01 CNY. Compared to the current market price of 70.7 CNY, Shenzhen New Industries Biomedical Engineering Co Ltd is Overvalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
68.01 CNY
Overvaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

14.1
P/S
P/S
Price to Sales
14.1
vs History
46
vs Industry
10
Median 3Y
14
Median 5Y
14.1
Industry
2.4
Forward
10.9
More Details
33.6
P/E
P/E
Price to Earnings
33.6
vs History
46
vs Industry
16
Median 3Y
33.6
Median 5Y
33.6
Industry
23.4
Forward
26
More Details
39.2
P/OCF
P/OCF
Price to OCF
39.2
vs History
72
vs Industry
9
Median 3Y
43.2
Median 5Y
43.9
Industry
15.5
More Details
50.7
P/FCFE
P/FCFE
Price to FCFE
50.7
vs History
84
vs Industry
12
Median 3Y
67.5
Median 5Y
68
Industry
23.2
More Details
7.4
P/B
P/B
Price to Book Value
7.4
vs History
40
vs Industry
9
Median 3Y
7
Median 5Y
7.1
Industry
2.3
More Details
13.3
EV/S
EV/S
Enterprise Value to Sales
13.3
vs History
42
vs Industry
10
Median 3Y
13
Median 5Y
13.1
Industry
2.5
Forward
10.2
More Details
18.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
18.2
vs History
43
vs Industry
10
Median 3Y
17.9
Median 5Y
18
Industry
5.3
More Details
29.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
29.2
vs History
46
vs Industry
10
Median 3Y
29
Median 5Y
29.1
Industry
12.6
Forward
20.8
More Details
29.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
29.2
vs History
46
vs Industry
15
Median 3Y
29
Median 5Y
29.1
Industry
17.2
Forward
22.7
More Details
36.8
EV/OCF
EV/OCF
Enterprise Value to OCF
36.8
vs History
68
vs Industry
10
Median 3Y
39.7
Median 5Y
40.3
Industry
15.3
More Details
47.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
47.6
vs History
84
vs Industry
10
Median 3Y
61.7
Median 5Y
62.8
Industry
19.8
More Details
11.1
EV/IC
EV/IC
Enterprise Value to IC
11.1
vs History
62
vs Industry
7
Median 3Y
11.5
Median 5Y
12.1
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Shenzhen New Industries Biomedical Engineering Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
55.6B CNY 14.1 33.6 29.2 29.2
JP
Hoya Corp
TSE:7741
6.4T JPY 8.5 38.3 23.2 28.7
CH
Alcon AG
SIX:ALC
35.6B CHF 4.2 40.4 18 36.6
DK
Coloplast A/S
CSE:COLO B
193.3B DKK 7.7 39.7 26.1 30.3
US
Align Technology Inc
NASDAQ:ALGN
21.7B USD 5.5 46.9 25.8 31.3
US
Cooper Companies Inc
NYSE:COO
18B USD 4.9 61.9 22.7 38.5
KR
HLB Inc
KOSDAQ:028300
13.3T KRW 310 -70.3 -114.6 -105.7
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP 3.1 51.1 46.8 50.9
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
5.9B USD 1.5 -44.4 11.5 24.7
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.2B USD 4 15.8 11.6 13.4
CH
Ypsomed Holding AG
SIX:YPSN
4.6B CHF 8.9 62.9 29.8 58.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.